Industry & Hardware
Manifold Bio
United States
About
Manifold Bio develops a high throughput in vivo platform that enables simultaneous testing of hundreds of biologics in a single animal to generate large-scale datasets for AI-driven development of tissue-targeting medicines, focusing initially on neuroshuttles.
Explore Manifold Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.